Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02431247
Brief Title: A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects

First Submitted : April 27, 2015
First Submitted that Met QC Criteria : April 27, 2015
First Posted : April 30, 2015 (Estimate)

Results First Submitted : August 15, 2018
Results First Submitted that Met QC Criteria : August 15, 2018
Results First Posted : September 14, 2018

Certification/Extension First Submitted : March 2, 2018
Certification/Extension First Submitted that Met QC Criteria : March 2, 2018
Certification/Extension First Posted : March 5, 2018

Last Update Submitted that Met QC Criteria : September 1, 2020
Last Update Posted : September 2, 2020